Judge Reinstates Georgia's Ban On Puberty Blockers, Hormone Therapies For Minors Authored by Caden Pearson via The Epoch Times (emphasis ours), A...
A team of scientists from the University of California, Irvine, believe they have discovered a special antibody which may lead to a treatment for Retinitis...
MIAMI, FLORIDA (Sept. 6, 2023) – A new study from researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of...
Australian patients with chronic health issues prescribed medical cannabis showed significant improvements in overall health-related quality of life and...
A team of clinical psychologists at VCU Massey Cancer Center received a four-year, $1.5 million grant from the U.S. Department of Defense (DOD) to help...
Although about half of people go through menopause, less than 15% of them receive effective treatment for their symptoms. Treatment options for people...
Biogen has appointed Jane Grogan as its new head of research. The move comes after CEO Chris Viehbacher said earlier this year he would split up...
For the 314,000 people diagnosed with ovarian cancer each year, hope often comes in the form of platinum-based drugs such as cisplatin. Credit: Larry Ostby,...
Cardiovascular disease and cancer share many parallels in their origins and how they develop. Nanoparticles offer one potential way to effectively treat...
Shankar Ramaswamy’s Kriya Therapeutics has acquired another gene therapy startup for an undisclosed amount. Fatima Bosch Kriya has purchased Tramontane...
In this webinar, sponsored by Thermo Fisher Scientific, our special guest Jonathan Bones from NIBRT, will demonstrate approaches to over come key challenges...
Peanut allergies proved a tough nut to crack for Nestlé, which announced Monday it has divested its treatment Palforzia to Swiss allergy specialist Stallergenes...
Osaka, Japan – Malignant melanoma is a type of skin cancer that originates from melanocytes or nevi, causing about 80% of skin cancer-related deaths....
Star Therapeutics, which created two antibody-focused biotech startups with more in the works, has now reeled in a $90 million Series C. The round, disclosed...
Cantor Fitzgerald announced on Tuesday that Eric Schmidt and Josh Schimmer are joining its biotech research group. Josh Schimmer Schimmer is a former senior...
An RNA editing therapy may be headed into human testing for the first time, after Wave Life Sciences submitted an application to bring the treatment into...
The Delights Of The Pfizer/Moderna Catfight Authored by Robert Malone via The Brownstone Institute, I am a bit embarrassed to admit that...
WEST LAFAYETTE, Ind. – A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet...
Music fans who were unable to purchase tickets to see one of their favorite bands on the Strip will be able to visit a special band-related...
Conflicting Evidence Of mRNA Technology Raises Serious Concerns About Rush For Use In New Vaccine Development Authored by Megan Redshaw via...
Representatives of the Colorado Natural Medicine Division will host five “listening sessions” throughout September and October to engage stakeholders...
It’s normal for desire to change and fluctuate – even on a daily basis.
UMC Utrecht will lead an international consortium that will try to answer a key question that’s in the mind of many pediatricians, infectiologists, pulmonologists...
Women’s wellbeing paradox: unhappier than men but more social, with higher levels of emotional resilience.
Hypermobility can be painful and lead to frequent injuries and systemic health problems. Unfortunately, many doctors aren’t familiar with these conditions,...
From Cambridge, U.K., to Cambridge, MA, and from creating better cytokines to aiding gene therapy, the development of new amino acids is likely to open...
Burn, trauma, and plastic surgery patients and others needing skin autografts often have limited quantities of healthy tissue from which to take skin biopsies,...
Complications of viral vectors can be avoided with DNA plasmids, engineered vesicles, cell-penetrating proteins, and other nonviral alternatives. To skirt...
As more companies invest in developing and refining their liquid biopsy technologies and entering key partnerships, it is likely that there are even more...
In this point of view Evan Floden, co-founder and CEO of Seqera Labs, suggests that the healthcare-related goals in a new White House Office of Science...